Direct award decision, Pulsiocare hemodynamic monitor and device-specific consumables from 2026, Getinge Finland Oy
Etelä-Savo Wellbeing Services County has requested a quote for a Pulsiocare hemodynamic monitor, including consumables, for the intensive care and monitoring unit of Mikkeli Central Hospital, starting from 2026. The procurement includes the device, consumables such as PiCCO catheters and ProAQT sensors, as well as device calibration for an indefinite contract period.
The Mikkeli Central Hospital Intensive Care Unit treats critically ill adult patients with severe circulatory disorders, such as septic shock, cardiogenic shock, multiple organ failure, severe respiratory failure (ARDS), post-operative conditions after major surgeries, and polytrauma patients. The treatment of these patients requires continuous and precise hemodynamic assessment to support fluid management, vasoactive medication, and prevention of organ damage. The PiCCO system is particularly used in situations where conventional monitoring or uncalibrated cardiac output monitors do not provide sufficient information for treatment decisions.
The unit currently uses ultrasound diagnostics and Swan Ganz catheters in the treatment of patients with severe circulatory failure. Echocardiography primarily provides a snapshot assessment rather than continuous information on the circulatory response to interventions. The European Society of Intensive Care Medicine (ESICM) emphasizes the primacy of echocardiography in the assessment of shock but also states that continuous monitoring of cardiac output and stroke volume should be used if the initial treatment does not yield a sufficient response or if monitoring of the treatment response requires it.
Conventional monitoring values, such as blood pressure, heart rate, and urine output, do not provide sufficient information to support treatment decisions in these situations. The alternative monitoring methods in use also do not allow for simultaneous measurement of all critical hemodynamic variables, or their reliability decreases in severely ill patients.
The PiCCO monitoring system to be procured enables the measurement of cardiac output and key variables for circulation and fluid balance from the same system. The system allows for simultaneous assessment of the patient's circulatory filling status and the amount of fluid accumulated in the lungs, which is crucial for targeting fluid therapy and monitoring the treatment response.
In practice, the need for procurement is based on recurring patient situations where it is critical for treatment decisions to assess whether the patient still benefits from fluid therapy or if additional fluid increases the risk of respiratory failure and pulmonary edema. This information can help avoid complications from both under- and over-hydration and support patient-safe, evidence-based intensive care.
The PiCCO system, based on thermodilution, is currently the only identified monitoring method that enables the production of this data from a single measurement, in addition to continuous cardiac output monitoring.
A quote has been requested via email, and negotiations have been held with Getinge Finland Oy.
The estimated total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold. The estimated total value is calculated for a 48-month period for an indefinite contract. The procurement is in accordance with the Common Procurement Vocabulary (CPV) of the European Union, CPV code 33100000-1.
The contracting entity may choose direct award on the following grounds:
Act on Public Procurement and Concession Contracts (1397/2016) Section 40 Direct Award
2) for technical reasons or reasons relating to the protection of exclusive rights, only a specific supplier can carry out the procurement; an additional condition is that there are no reasonable alternative or substitute solutions and that the lack of competition is not due to an artificial restriction of the procurement conditions. The contracting entity may choose direct award on the aforementioned grounds because the assessment of the clinical need of the intensive care unit has examined the available hemodynamic monitoring methods and their measurement methods in relation to the clinical need described above. The assessment found that the uncalibrated pulse wave-based systems in use and available on the market do not provide measurement data for extravascular lung water (EVLWI) and global end-diastolic volume (GEDI), which are essential for the unit's operations in optimizing fluid therapy and circulation for critically ill intensive care patients.
According to the unit's assessment, the PiCCO system is the only identified solution that simultaneously meets the requirements for continuous hemodynamic monitoring and measurement of lung water and preload based on transpulmonary thermodilution. For this reason, no alternative solution meeting the technical and functional requirements has been identified.
The device procurement, Pulsiocare hemodynamic monitor, costing EUR 15,800 (excl. VAT), will be funded from the investment appropriations for 2026 (investment number 1120).
The total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold and consists of the device's purchase price, device-specific consumables procured under an indefinite contract, and post-warranty calibration. Eloisa commits to ordering 7 boxes of PiCCO catheters and 4 boxes of ProAQT sensors annually.
The total value of the procurement is calculated for a 48-month period for an indefinite contract.
Lot 1: Direct award decision, Pulsiocare hemodynamic monitor and device-specific consumables from 2026, Getinge Finland Oy
Etelä-Savo Wellbeing Services County has requested a quote for a Pulsiocare hemodynamic monitor, including consumables, for the intensive care and monitoring unit of Mikkeli Central Hospital, starting from 2026. The procurement includes the device, consumables such as PiCCO catheters and ProAQT sensors, as well as device calibration for an indefinite contract period. The unit currently uses ultrasound diagnostics and Swan Ganz catheters in the treatment of patients with severe circulatory failure. Echocardiography primarily provides a snapshot assessment rather than continuous information on the circulatory response to interventions. The European Society of Intensive Care Medicine (ESICM) emphasizes the primacy of echocardiography in the assessment of shock but also states that continuous monitoring of cardiac output and stroke volume should be used if the initial treatment does not yield a sufficient response or if monitoring of the treatment response requires it. Conventional monitoring values, such as blood pressure, heart rate, and urine output, do not provide sufficient information to support treatment decisions in these situations. The alternative monitoring methods in use also do not allow for simultaneous measurement of all critical hemodynamic variables, or their reliability decreases in severely ill patients. The PiCCO monitoring system to be procured enables the measurement of cardiac output and key variables for circulation and fluid balance from the same system. The system allows for simultaneous assessment of the patient's circulatory filling status and the amount of fluid accumulated in the lungs, which is crucial for targeting fluid therapy and monitoring the treatment response. In practice, the need for procurement is based on recurring patient situations where it is critical for treatment decisions to assess whether the patient still benefits from fluid therapy or if additional fluid increases the risk of respiratory failure and pulmonary edema. This information can help avoid complications from both under- and over-hydration and support patient-safe, evidence-based intensive care. The PiCCO system, based on thermodilution, is currently the only identified monitoring method that enables the production of this data from a single measurement, in addition to continuous cardiac output monitoring. A quote has been requested via email, and negotiations have been held with Getinge Finland Oy. The estimated total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold. The estimated total value is calculated for a 48-month period for an indefinite contract. The procurement is in accordance with the Common Procurement Vocabulary (CPV) of the European Union, CPV code 33100000-1. The contracting entity may choose direct award on the following grounds: Act on Public Procurement and Concession Contracts (1397/2016) Section 40 Direct Award 2) for technical reasons or reasons relating to the protection of exclusive rights, only a specific supplier can carry out the procurement; an additional condition is that there are no reasonable alternative or substitute solutions and that the lack of competition is not due to an artificial restriction of the procurement conditions. The contracting entity may choose direct award on the aforementioned grounds because the assessment of the clinical need of the intensive care unit has examined the available hemodynamic monitoring methods and their measurement methods in relation to the clinical need described above. The assessment found that the uncalibrated pulse wave-based systems in use and available on the market do not provide measurement data for extravascular lung water (EVLWI) and global end-diastolic volume (GEDI), which are essential for the unit's operations in optimizing fluid therapy and circulation for critically ill intensive care patients. According to the unit's assessment, the PiCCO system is the only identified solution that simultaneously meets the requirements for continuous hemodynamic monitoring and measurement of lung water and preload based on transpulmonary thermodilution. For this reason, no alternative solution meeting the technical and functional requirements has been identified. The device procurement, Pulsiocare hemodynamic monitor, costing EUR 15,800 (excl. VAT), will be funded from the investment appropriations for 2026 (investment number 1120). The total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold and consists of the device's purchase price, device-specific consumables procured under an indefinite contract, and post-warranty calibration. Eloisa commits to ordering 7 boxes of PiCCO catheters and 4 boxes of ProAQT sensors annually. The total value of the procurement is calculated for a 48-month period for an indefinite contract.